Technical Analysis for SILO - Silo Pharma, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 0.98 | -1.60% | -0.02 |
SILO closed down 1.6 percent on Monday, July 1, 2024, on 3 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| NR7 | Range Contraction | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Bullish Engulfing | Bullish | -1.60% | |
| MACD Bullish Signal Line Cross | Bullish | -1.60% | |
| New 52 Week Low | Weakness | -1.60% | |
| Wide Bands | Range Expansion | -1.60% | |
| Gapped Down | Weakness | -1.60% | |
| Oversold Stochastic | Weakness | -1.60% |
| Alert | Time |
|---|---|
| Possible NR7 | about 6 hours ago |
| Down 3% | about 10 hours ago |
| Down 2 % | about 10 hours ago |
| Down 1% | about 10 hours ago |
| Up 2% | 3 days ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 02/28/2024
Silo Pharma, Inc. operates as a developmental stage biopharmaceutical company. The company focuses on merging traditional therapeutics with psychedelic research for patients with depression, post-traumatic stress disorder, Alzheimer's, Parkinson's, and other rare neurological disorders. It has a scientific research agreement with the University of Maryland, The Regents of the University of California, and Columbia University. The company was formerly known as Uppercut Brands, Inc. and changed its name to Silo Pharma, Inc. in September 2020. Silo Pharma, Inc. was incorporated in 2010 and is headquartered in Englewood Cliffs, New Jersey.
Sector: Healthcare
Industry: Biotechnology
Keywords: Alzheimer's Disease Parkinson's Disease Depression Post Traumatic Stress Disorder Rare Neurological Disorders
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Alzheimer's Disease Parkinson's Disease Depression Post Traumatic Stress Disorder Rare Neurological Disorders
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 3.05 |
| 52 Week Low | 0.9111 |
| Average Volume | 276,572 |
| 200-Day Moving Average | 1.61 |
| 50-Day Moving Average | 1.61 |
| 20-Day Moving Average | 1.18 |
| 10-Day Moving Average | 1.01 |
| Average True Range | 0.15 |
| RSI (14) | 34.21 |
| ADX | 19.13 |
| +DI | 18.84 |
| -DI | 28.89 |
| Chandelier Exit (Long, 3 ATRs) | 2.12 |
| Chandelier Exit (Short, 3 ATRs) | 1.36 |
| Upper Bollinger Bands | 1.84 |
| Lower Bollinger Band | 0.52 |
| Percent B (%b) | 0.35 |
| BandWidth | 111.99 |
| MACD Line | -0.20 |
| MACD Signal Line | -0.21 |
| MACD Histogram | 0.0064 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 1.04 | ||||
| Resistance 3 (R3) | 1.04 | 1.02 | 1.03 | ||
| Resistance 2 (R2) | 1.02 | 1.01 | 1.02 | 1.03 | |
| Resistance 1 (R1) | 1.00 | 1.00 | 0.99 | 1.00 | 1.03 |
| Pivot Point | 0.98 | 0.98 | 0.98 | 0.98 | 0.98 |
| Support 1 (S1) | 0.96 | 0.97 | 0.95 | 0.96 | 0.94 |
| Support 2 (S2) | 0.94 | 0.96 | 0.94 | 0.94 | |
| Support 3 (S3) | 0.92 | 0.94 | 0.93 | ||
| Support 4 (S4) | 0.92 |
